Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 19,015 | 7,233 | 1,673 | -1,354 | -2,341 |
| Depreciation Amortization | 4,006 | 3,452 | 3,367 | 3,474 | 3,337 |
| Income taxes - deferred | -11,732 | 469 | -757 | -474 | 682 |
| Accounts receivable | -1,088 | 3,233 | -391 | 2,238 | -2,748 |
| Accounts payable and accrued liabilities | 56 | -1,024 | -478 | -83 | 1,229 |
| Other Working Capital | -1,237 | 5,206 | -1,564 | 2,349 | -297 |
| Other Operating Activity | 3,273 | -2,060 | 7,352 | 5,905 | 8,494 |
| Operating Cash Flow | $12,293 | $16,509 | $9,202 | $12,055 | $8,356 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -813 | -1,372 | -1,308 | -1,452 | -2,382 |
| Net Acquisitions | -7,115 | -20,764 | -752 | -5,089 | -1,118 |
| Other Investing Activity | -418 | -164 | -568 | -11 | -281 |
| Investing Cash Flow | $-8,346 | $-22,300 | $-2,628 | $-6,552 | $-3,781 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,350 | 16,900 | 1,650 | 12,281 | N/A |
| Debt Repayment | -5,663 | -3,674 | -7,920 | -9,807 | -5,521 |
| Common Stock Issued | 282 | 271 | 911 | 722 | 235 |
| Common Stock Repurchased | -5,000 | -2,404 | -2,596 | N/A | N/A |
| Other Financing Activity | 0 | -1,308 | 0 | -166 | 0 |
| Financing Cash Flow | $-31 | $9,785 | $-7,955 | $3,030 | $-5,286 |
| Exchange Rate Effect | -800 | -1,104 | -3,125 | -80 | 691 |
| Beginning Cash Position | 16,588 | 13,698 | 18,204 | 9,751 | 9,771 |
| End Cash Position | 19,704 | 16,588 | 13,698 | 18,204 | 9,751 |
| Net Cash Flow | $3,116 | $2,890 | $-4,506 | $8,453 | $-20 |
| Free Cash Flow | |||||
| Operating Cash Flow | 12,293 | 16,509 | 9,202 | 12,055 | 8,356 |
| Capital Expenditure | -844 | -1,376 | -1,308 | -1,452 | -2,382 |
| Free Cash Flow | 11,449 | 15,133 | 7,894 | 10,603 | 5,974 |